Kala Pharmaceuticals, Inc.【KALA】 純有利子負債の推移

機能の使い方
(単位:千ドル) 純有利子負債 前年比(%)
1Q25 -11,598 -17.0%
4Q24 -20,743 +24.2%
3Q24 -14,063 -36.6%
2Q24 -19,380 -24.3%
1Q24 -13,976 -54.0%
4Q23 -16,705 -39.4%
3Q23 -22,185 +127.5%
2Q23 -25,609 -172.7%
1Q23 -30,370 -430.1%
4Q22 -27,558 +108.7%
3Q22 -9,751 -78.8%
2Q22 35,232 -149.2%
1Q22 9,199 -111.0%
4Q21 -13,207 -83.8%
3Q21 -46,012 -47.2%
2Q21 -71,580 -36.6%
1Q21 -83,464 -
4Q20 -81,297 -
3Q20 -87,153 -
2Q20 -112,862 -
1Q19 -81,062 -2.3%
4Q18 -112,878 +17.5%
3Q18 -57,299 -44.0%
2Q18 -73,616 +342.4%
1Q18 -82,955 -
4Q17 -96,045 -
3Q17 -102,309 -
2Q17 -16,640 -